Buckingham Capital Management, Inc. Novartis Ag Transaction History

Buckingham Capital Management, Inc.

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$84.35 - $95.37 $197,294 - $223,070	-2,339 Closed	0 $0
Q3 2019 Nov 12, 2019	BUY	$85.54 - $94.26 $200,078 - $220,474	2,339 New	2,339 $203,000
Q2 2019 Aug 09, 2019	SELL	$75.4 - $92.8 $178,245 - $219,379	-2,364 Closed	0 $0
Q1 2019 May 07, 2019	BUY	$75.32 - $86.15 $178,056 - $203,658	2,364 New	2,364 $227,000
Q4 2018 Feb 04, 2019	SELL	$73.66 - $82.02 $185,181 - $206,198	-2,514 Closed	0 $0
Q3 2018 Nov 20, 2018	SELL	$66.94 - $77.43 $39,561 - $45,761	-591 Reduced 19.03%	2,514 $217,000
Q4 2017 Feb 13, 2018	SELL	$72.33 - $77.64 $23,941 - $25,698	-331 Reduced 9.63%	3,105 $261,000
Q3 2017 Nov 07, 2017	SELL	$74.14 - $77.27 $9,564 - $9,967	-129 Reduced 3.62%	3,436 $295,000
Q2 2017 Aug 10, 2017	BUY	N/A	3,565	3,565 $298,000

1,437

133M

1.12M

1.83M

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $226B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

Get notified when there are updates to the investment portfolio of Buckingham Capital Management, Inc., based on Form 13F filings with the SEC.

Stay updated on Buckingham Capital Management, Inc. with notifications on news.